Janus Henderson Group’s Fulgent Genetics FLGT Stock Holding History

Janus Henderson Group’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-99,206	Closed	-$2.87M	–	2545
2023 Q4	$2.87M	Sell	99,206 -10,751	-10%	-$288K	﹤0.01%	1059
2023 Q3	$2.94M	Buy	109,957 +28,679	+35%	+$979K	﹤0.01%	999
2023 Q2	$3.01M	Buy	81,278 +20,780	+34%	+$724K	﹤0.01%	1038
2023 Q1	$1.89M	Buy	60,498 +23,490	+63%	+$756K	﹤0.01%	1299
2022 Q4	$1.1M	Sell	37,008 -44,860	-55%	-$1.61M	﹤0.01%	1301
2022 Q3	$3.12M	Buy	81,868 +40,578	+98%	+$2.03M	﹤0.01%	1133
2022 Q2	$2.25M	Buy	41,290 +8,270	+25%	+$455K	﹤0.01%	1008
2022 Q1	$2.06M	Sell	33,020 -9,757	-23%	-$642K	﹤0.01%	1216
2021 Q4	$4.3M	Buy	42,777 +3,075	+8%	+$270K	﹤0.01%	1100
2021 Q3	$3.57M	Sell	39,702 -7,943	-17%	-$722K	﹤0.01%	1131
2021 Q2	$4.39M	Buy	+47,645	New	+$3.8M	﹤0.01%	1088

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Janus Henderson Group's FLGT Position: Q1 2024 in Review

Janus Henderson Group sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 99,206 shares — an estimated $2.87M sold.

Janus Henderson Group first reported a position in FLGT in Q2 2021 and held it in 11 quarters. The position peaked at $4.39M in Q2 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

Janus Henderson Group reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
Janus Henderson Group sold 99,206 Fulgent Genetics shares in Q1 2024, an estimated $2.87M.
Janus Henderson Group first reported a position in Fulgent Genetics in Q2 2021 and held it in 11 quarters.
Janus Henderson Group's Fulgent Genetics position peaked at $4.39M in Q2 2021.
180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.